Federated Hermes, Inc. Sage Therapeutics, Inc. Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

A detailed history of Federated Hermes, Inc. transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 675,347 shares of SAGE stock, worth $3.67 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

675,347

Previous 670,468 0.73%

Holding current value

$3.67 Million

Previous $7.28 Million 33.13%

% of portfolio

0.01%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$7.02 - $13.08 $34,250 - $63,817	4,879 Added 0.73%	675,347 $4.87 Million
Q2 2024 Aug 08, 2024	BUY	$10.58 - $17.9 $7.09 Million - $12 Million	670,468 New	670,468 $7.28 Million
Q4 2023 Jan 31, 2024	SELL	$17.1 - $22.26 $2.83 Million - $3.68 Million	-165,451 Reduced 99.68%	534 $11,000
Q3 2023 Nov 13, 2023	BUY	$16.75 - $48.98 $2.78 Million - $8.13 Million	165,985 New	165,985 $3.42 Million
Q2 2022 Aug 15, 2022	SELL	$27.52 - $37.99 $489,305 - $675,462	-17,780 Reduced 70.1%	7,584 $245,000
Q1 2022 May 13, 2022	SELL	$30.71 - $45.71 $434,700 - $647,025	-14,155 Reduced 35.82%	25,364 $840,000
Q4 2021 Feb 14, 2022	BUY	$37.06 - $47.11 $202,829 - $257,833	5,473 Added 16.08%	39,519 $1.68 Million
Q3 2021 Nov 15, 2021	BUY	$40.26 - $57.37 $247,236 - $352,309	6,141 Added 22.01%	34,046 $1.51 Million
Q2 2021 Aug 16, 2021	BUY	$54.88 - $79.29 $204,921 - $296,068	3,734 Added 15.45%	27,905 $1.59 Million
Q1 2021 May 13, 2021	SELL	$70.65 - $96.76 $9.66 Million - $13.2 Million	-136,696 Reduced 84.97%	24,171 $1.81 Million
Q4 2020 Feb 12, 2021	SELL	$58.41 - $89.06 $3.51 Million - $5.36 Million	-60,175 Reduced 27.22%	160,867 $13.9 Million
Q3 2020 Nov 12, 2020	BUY	$41.13 - $62.45 $143,420 - $217,763	3,487 Added 1.6%	221,042 $13.5 Million
Q2 2020 Aug 13, 2020	BUY	$25.95 - $43.15 $3.67 Million - $6.1 Million	141,313 Added 185.35%	217,555 $9.05 Million
Q1 2020 May 13, 2020	BUY	$26.15 - $77.24 $1.99 Million - $5.89 Million	76,242 New	76,242 $2.19 Million
Q3 2019 Nov 14, 2019	SELL	$140.29 - $189.96 $677,600 - $917,506	-4,830 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$157.85 - $183.09 $762,415 - $884,324	4,830 New	4,830 $884,000
Q3 2018 Nov 13, 2018	SELL	$138.11 - $169.04 $745,655 - $912,646	-5,399 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$140.36 - $175.76 $3.97 Million - $4.97 Million	-28,271 Reduced 83.96%	5,399 $845,000
Q1 2018 May 09, 2018	BUY	$152.15 - $192.33 $3.55 Million - $4.48 Million	23,316 Added 225.19%	33,670 $5.42 Million
Q4 2017 Feb 14, 2018	SELL	$60.72 - $167.34 $45.1 Million - $124 Million	-742,203 Reduced 98.62%	10,354 $0
Q3 2017 Nov 13, 2017	BUY	$61.4 - $88.52 $46.2 Million - $66.6 Million	752,557	752,557 $46.9 Million

Others Institutions Holding SAGE

# of Institutions

198

Shares Held

46.5M

Call Options Held

402K

Put Options Held

209K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $323M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Sage Therapeutics, Inc. Transaction History